top of page

We are a Faith Based
HealthTech Venture Firm
Seeking Outstanding
Financial, Social & Purpose Driven Returns...

Be The Miracle!

Results

PRIOR FUND RESULTS

image.png
TEAM

Team (GP's)

Bob G.png
dartmouth.png
HBS.png
Warburg.png
summit.png
Polaris.png

Bob Geiman (Co-Founder & Managing Partner): In his career, Bob has sourced and/or led investments in over 75 companies, representing over $400 million in invested capital returning over $3 billion. He is Co-CEO and Co-Founder of Cava Studio and a Managing Partner of CavaCapital, a venture firm building valuable technology and consumer lifestyle businesses and investing in visionary entrepreneurs. While at Cava, Bob was the Founder and CEO of Confirm, a leader in mobile document and identity authentication sold to Facebook in 2018. Prior to Confirm, Bob founded and served as CEO of EveryScreen Media, a mobile advertising and technology company (acquired by Dstillery in 2013).EveryScreen Media, Confirm were both launched as Cava Studio projects in 2011 and 2015 respectively.

​

Bob has over 25 years of investing and senior leadership experience as a venture and growth equity investor. In addition to Cava, Bob serves as an Entrepreneur in Residence with Summit Partners, a large private equity firm, where he focused on digital transaction enablement, and an Advisory Board member of G20 Ventures, a venture capital firm that focuses on making Series A investments in enterprise software companies. Previously, Bob served as an Entrepreneur in Residence at Warburg Pincus, focused on companies in the mobile and artificial intelligence sectors. In addition, he was a General Partner at Polaris Venture Partners for 8 years, where he made numerous early-stage and later-stage investments in the mobile and media sectors. Bob also launched the firm’s proactive sourcing strategy, hiring and managing a team of eight associates who were proactively sourcing investments. Bob started his career as an associate at Summit Partners, a Boston-based private equity firm, where he focused on making investments in technology businesses. He currently serves on the advisory boards of numerous Internet and digital media startups in Boston and New York City. Bob has served on dozen of Boards and Advisory Boards of technology companies.

​

Earlier in his career, Bob served in various product, business development, and strategy roles at Envoy Networks (wireless communications components) and helped sell that company to Texas Instruments in 2001. Prior to Envoy, Bob was a member of the management team of MCK Communications (VoIP-based communications software and hardware) that grew MCK from an unprofitable, 25-person company with $5 million in revenue to a 290-person public company with $60 million in revenue and significant cash flow and profitability.

​

Bob holds an M.B.A. from Harvard Business School and a B.A. from Dartmouth College.

​

linkedin.com/in/robertgeiman

​

​

Andrew.png
uconn.png
GE.png
trw.png
Bankrate.png
1Flourish Logo 3.png

Andrew Miller (Founder & Managing Partner): Andrew is active angel investor having invested in over 25 startups over his career including 2 unicorns.  He was the founding partner for the 1st faith based venture firm in the US and today he is pursuing his second fund HealthTech Venture Capital focused on bringing AI solutions to the medical industry.

 

Prior to founding 1Flourish (18 Investments), Andrew was a 3-time CEO; former Fortune 15 leadership executive with GE Capital, (EVP) &  TRW (President); part of the executive team taking Bankrate.com public.  Functional Expertise includes Operations, Marketing, Sales, Customer Service and active in multiple M&A events during his career.

 

Andrew was a 1st Team All Big East golfer and ranked 2nd in New England golf during his senior year and a graduate from the University of Connecticut School of Business and a 6 Sigma Blackbelt. He is a devoted father, husband and avid golfer. He attends the Church of the Resurrection in Overland Park Kansas.

​

linkedin.com/in/andrewsmiller1

Leaders.png
Iowa State.png
Owens.png

Andrew Micheal Leaders is a purpose-driven executive and a Founding Partner of Faith Partners Inc., a firm uniquely positioned to be the spark to ignite revenue for early-stage MedTech companies. As a dedicated partner to investors and founders, Andrew specializes in commercializing innovative, early-stage medical device organizations within the complex U.S. healthcare landscape. Andrew’s core mission is defined by a commitment to "Be the Shepherd"—providing purposeful guidance, protective care, and proactive support to clients, teams, and partners. This philosophy ensures every commercial strategy is marked by attentive wisdom and a deep sense of responsibility, driving superior outcomes that leave the healthcare environment measurably better.  Prior to founding Faith Partners Inc., Andrew established a distinguished 17-year career at Owens & Minor, culminating in executive leadership roles where he managed P&L responsibility for over $1 billion in annual business. His tenure is marked by large-scale, quantifiable transformation:

​

  • Financial & Operational Impact: Andrew spearheaded a commercial rapid business transformation that resulted in a $28 million year-over-year improvement to operating income, accounting for 14% of the company's posted results. He also led the Florida market, increasing its operating income by a dramatic 76% against the overall company’s flat performance.

  • Growth & Strategy: He drove 19% revenue growth over two years in the Provider & Health System segment and successfully renewed a top 10 Integrated Delivery Network (IDN) to a five-year exclusive deal by strategically restructuring go-to-market models. He expanded product portfolios by 31% and secured crucial national contracts with Group Purchasing Organizations (GPOs).

  • Scaling Early-Stage Revenue: Andrew’s ability to build and scale high-performing sales organizations is evident in his subsequent role as Area Vice President at SourceMark Medical, where he achieved 73% revenue growth and successfully recruited 3 Directors and 32 independent Sales Representatives to build a national 1099 team from the ground up.

​

Andrew’s leadership philosophy, centered on "Leading through love," challenges the status quo by committing to excellence and radical generosity ("Be the Miracle"). His ability to integrate distribution, products, services, and solutions to redefine value propositions for large IDNs makes him an invaluable strategic partner for MedTech companies seeking rapid, sustainable market penetration. His contributions to the industry have earned him significant recognition, including the Bellwether League Future Famer designation (2018) and the O&M Excellence in Leadership Award (2016). He is a recognized thought leader, having presented at major conferences, including the WSHMMA and AHRMM National Conference, on critical topics such as the state of the healthcare supply chain and pandemic preparedness.

Andrew holds a B.S. in Marketing from Iowa State University, where he was a football letter winner, team captain, and defensive advisor. Based in Kansas City, MO, he is deeply committed to community service, supporting A Turning Point homeless shelter, the Falcon Feeder basketball academy, and the Joy Up Charity Foundation, which his daughter started after her own heart surgery journey to support underserved youth.

Dick Flanagan.png
John Hopkins.png
cerner.png
IBM.png

Dick Flanigan is currently the President of a community-based not for profit initiative, Digital Health KC, that seeks to leverage the wealth of health IT talent in the region with an objective of growing KC’s national presence as a leader in digital health. DHKC helps to create the conditions where ideas flourish and entrepreneurs and operators can work together on solving healthcare's biggest challenges. DHKC sponsors monthly meet-ups and Healthcare 201 education sessions along with the DHKC Digital Health Day which attracted over 450 attendees. DHKC is part of BioNexus KC, the region’s life sciences convener and collaborator. www.digitalhealthKC.org In addition to my role at Digital Health KC, I am currently advising and investing in early stage digital health companies and Venture Funds in the region and beyond through RJF Advisory, LLC.

I retired from Oracle Cerner where I served as a global leader and senior executive for more than 27 years. Prior to that I spent 13+ years at IBM learning many industries for the first 9 years until I engineered my way into covering healthcare full time. This combination of understanding the power of information technology to shape industries and a deep commitment to healthcare has powered my career for decades. At Cerner I have managed business units that included Regions, Product Groups, Managed Services Outsourcing, Life Sciences and Research, and Employer Health Services. I led or co-led the acquisition and integration of 8 companies including Siemens Health Services, Cerner's largest acquisition ($1.3B). Most recently, I was responsible for Cerner's Regulatory Strategy as well as overseeing two strategically aligned clients at the University of Missouri Healthcare and Children's National Hospital. At Cerner, I gained experience in leading large organizations and driving an aligned strategy to deliver client outcomes and Cerner business results.

I am a Fellow in the American College of Healthcare Execs (FACHE) and was a CHIME Foundation Certified Healthcare Executive (CFCHE). I am committed to the health and development of my community. I serve on the Boards of UMKC and Donnelly College. I served on the Advisory Board of Center for Practical Bio-Ethics' Taskforce on the Ethical Use of AI.

https://www.linkedin.com/in/dickflaniganks/

OUR SECTORS

Sectors
devices 9.jpg

Market Drivers: 

  • Market Size: USD 26.57 Billion

  • 2030 Projected Market Size: USD 187.69 Billion

  • CAGR (2025-2030): 38.62%

  • North America: Largest market in 2024

GLOBAL IT

Market Drivers: 

  • The global healthcare IT market is a rapidly growing sector, with a projected market size of $834.35 billion by 2029, growing from $420.23 billion in 2024

  • Increasing use of digital health technologies, such as electronic health records (EHRs), remote patient monitoring, and telemedicine

MED DEVICE

Market Drivers: 

  • USD 256.2 billion in 2024, projected to grow at a CAGR of 5.9% from 2025 to 2030.

  • An aging population:

  • Technological advancements: Innovations in areas like AI, robotics, digital health, wearable devices, and minimally invasive surgery are expanding the market.

  • High adoption of minimally invasive procedures:

  • Acquisitions and collaborations allow manufacturers to access new markets and expand their customer base.

  • Growing prevalence of chronic diseases:

BIO PHARMA

Scientist with Test Tubes

Market Drivers:

  • US pharmaceutical technology market, encompassing Pharma 4.0 which integrates Industry 4.0 technologies like IoT, AI, and blockchain, was valued at USD 4.44 billion in 2024. 

  • It is projected to reach approximately USD 20.37 billion by 2034, growing at a compound annual growth rate (CAGR) of 17.3% from 2024 to 2034. 

  • Rising Demand for Personalized Medicine and Precision Medicine

  • Increasing Need for Efficiency and Cost-Effectiveness

  • Digital Transformation and Patient-Centric Approaches

Contact Us

Contact
Us

HealthTech Venture Capital

15912 Reeder Street 

Overland Park KS  66221

727 519 3949

Thanks for submitting!

Anchor 2

AI HEALTH CARE

  • White Facebook Icon
  • White Twitter Icon

© 2035 by Modern Finance. Powered and secured by Wix

bottom of page